Table 1.
Comparison of epidemiological and clinicopathological parameters between familial and sporadic breast cancer patients.
Fig 1.
Kaplan Meier estimates overall survival according to familial breast cancer status.
Blue line represents sporadic and green line familial cases.
Table 2.
Comparison of clinico-pathological features between 2 age groups (breast cancer patients ≤35 years and >35 years).
Table 3.
Correlation between Ki-67 expression and clinicopathological features in breast cancer patients.
Table 4.
Ki-67 cut-offs predicting survival in overall luminal breast cancer tumours.
Fig 2.
Kaplan Meier estimates overall survival according to comorbidity status.
Blue line represents non-comorbid patients and green line comorbid cases.